Nanjing First Hospital — Nanjing, Jiangsu

Public research footprint of Nanjing First Hospital, compiled from the ClinicalTrials.gov public registry.

314

Registered studies

121

Active

Recruiting now

120

Completed

Stopped or withdrawn

Most-studied conditions

Overweight · Type 2 Diabetes Mellitus · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Acute Ischemic Stroke AIS

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06411275 — A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes… (Completed)
NCT06350890 — Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nanjing First Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.